| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.46 | 0.007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.008 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |